A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH) (ZENITH)

Status

Active

DZG

DZL

Start date

05/21/2021

Parameters

Inclusion criteria
  • pulmonary arterial hypertension under treatment and still on high risk
Exclusion criteria
  • low risk PAH